Health
COVID-19 drug remdesivir has been a big win for Gilead — and it got a boost from taxpayers – San Francisco Chronicle
With U.S. cases skyrocketing, demand for the Foster City company’s antiviral drug is only growing. Biden appointees have proposed potential legal tactics to tamp…
It was the end of April — just as the U.S. confirmed its millionth COVID-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly significant” news about a drug called remdesivir.
That was surprising because the antiviral drug, owned by Gilead Sciences and developed with investment from the federal government, had languished for years with no apparent commercial use. It had struck out as a treatment for hepatitis C and Ebola.
But early in 2020, when the first global…
-
Business18 hours agoBell Potter names more of the best ASX 200 stocks to buy in April
-
Noosa News17 hours agoTeenager sentenced to 12 years for ‘heinous’ Acacia Ridge murder
-
Noosa News15 hours agoGirl’s death in a Queensland cult
-
General15 hours agoTeen driver on cocaine racing to Perth nightclub before high-speed crash that killed Nick Campo, court hears